Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rayto is a China-based in vitro diagnostics company focused on the development, manufacturing, sales, and service of clinical diagnostic instruments, related software, and some associated reagents. The company is best known for commercial laboratory and hospital testing systems spanning clinical chemistry, chemiluminescence immunoassay, hematology, coagulation, ELISA, urinalysis, and related workflows. Its product portfolio includes analyzer families such as Chemray, Lumiray, Hemaray, RAC, Blotray, and Protray, and its systems are marketed for use in hospitals, clinics, blood banks, disease-control settings, research laboratories, and veterinary applications. Rayto appears to be a privately held, active company headquartered in Shenzhen, China, with international distribution across many countries. It is a healthcare diagnostics equipment manufacturer rather than a therapeutic drug developer, so it does not have a conventional drug pipeline or clinical-stage therapeutics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rayto.